Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.
about
Management of Crohn's diseaseUse of Biologics in Pouchitis: A Systematic ReviewUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut.Treating children with inflammatory bowel disease: Current and new perspectives.Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability.Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target.Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.
P2860
Q26778252-FF0D89A0-CECC-4AC0-98E0-BD5E142D21E8Q26995117-523D3AC7-3A4C-4DD1-9011-C02A420D3B7DQ26996946-D71E9B8E-5C54-46E6-99A1-37E82C5A64DDQ34491388-5A4D21D1-1D2F-405B-8A97-955A2108E302Q38602911-FF6094B0-1084-4871-BE70-553F41090D9FQ41111300-BBF7C96C-9ED0-4845-9850-8DF19EEFC903Q47698698-E0CF85A6-6581-4A3E-8B90-CA668F08199CQ48518781-1D9131CC-DD0E-4F8E-89AB-DC6830FB5AA9Q49339951-E90B541A-6599-4DC0-9918-072D0705BA2D
P2860
Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Benefits and risks of combinin ...... ic inflammatory bowel disease.
@en
type
label
Benefits and risks of combinin ...... ic inflammatory bowel disease.
@en
prefLabel
Benefits and risks of combinin ...... ic inflammatory bowel disease.
@en
P2093
P2860
P1476
Benefits and risks of combinin ...... ic inflammatory bowel disease.
@en
P2093
Anne Griffiths
Dan Turner
Johanna C Escher
Lissy de Ridder
Martinus A Cozijnsen
P2860
P304
P356
10.1097/MIB.0000000000000245
P577
2015-04-01T00:00:00Z